By clicking on the hyperlinks provided for each article, you can access the abstract (summary) of the articles, when available, online via the National Library of Medicine’s PubMedTM database.
Review Articles
1. Optimizing ovulation induction in women with polycystic ovary syndrome.
Curr Opin Obstet Gynecol 2002 Jun;14(3):245-54.
http://www.medifocus.com/abstracts.a...14&ID=22027518
2. Polycystic ovary syndrome: a risk for coronary artery disease?. [Review] [25 refs]
American Journal of Obstetrics & Gynecology. 186(1):35-43, 2002 Jan.
http://www.medifocus.com/abstracts.a...14&ID=21667858
3. Polycystic ovaries. [Review] [54 refs]
British Journal of Radiology. 75(889):9-16, 2002 Jan.
http://www.medifocus.com/abstracts.a...14&ID=21665842
4. Clinical management of PCOS. [Review] [47 refs]
Acta Obstetricia et Gynecologica Scandinavica. 80(8):689-96, 2001 Aug.
http://www.medifocus.com/abstracts.a...14&ID=21422506
5. Polycystic ovary syndrome and insulin-resistant hyperinsulinemia. [Review] [64 refs]
Journal of the American Academy of Dermatology. 45(3 Suppl):S95-104, 2001 Sep.
http://www.medifocus.com/abstracts.a...14&ID=21402867
6. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. [Review] [33 refs]
Cochrane Database Syst Rev. (2):CD002121, 2001.
http://www.medifocus.com/abstracts.a...14&ID=21299257
7. Obesity, polycystic ovary syndrome and anovulation--how are they interrelated?. [Review] [28 refs]
Current Opinion in Obstetrics & Gynecology. 13(3):323-7, 2001 Jun.
http://www.medifocus.com/abstracts.a...14&ID=21289614
8. Polycystic ovary syndrome and ovulation induction. [Review] [98 refs]
Obstetrics & Gynecology Clinics of North America. 28(1):165-82, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21188639
9. Polycystic ovary syndrome, androgen excess, and the impact on bone. [Review] [89 refs]
Obstetrics & Gynecology Clinics of North America. 28(1):135-51, vii-viii, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21188637
10. Cardiovascular risk in women with polycystic ovary syndrome. [Review] [76 refs]
Obstetrics & Gynecology Clinics of North America. 28(1):111-33, vii, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21188636
11. Diabetes prevalence and risk factors in polycystic ovary syndrome. [Review] [48 refs]
Obstetrics & Gynecology Clinics of North America. 28(1):99-109, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21188635
12. Obesity and weight loss in polycystic ovary syndrome. [Review] [47 refs]
Obstetrics & Gynecology Clinics of North America. 28(1):85-97, vi-vii, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21188634
13. Polycystic ovary syndrome and hyperprolactinemia. [Review] [55 refs]
Obstetrics & Gynecology Clinics of North America. 28(1):77-84, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21188633
14. Polycystic ovary syndrome, hyperandrogenism, and insulin resistance. [Review] [59 refs]
Obstetrics & Gynecology Clinics of North America. 28(1):21-33, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21188630
15. Polycystic ovary syndrome. A diagnostic challenge. [Review] [96 refs]
Obstetrics & Gynecology Clinics of North America. 28(1):1-20, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21188629
16. The long term health consequences of polycystic ovary syndrome. [Review] [154 refs]
BJOG. 107(11):1327-38, 2000 Nov.
http://www.medifocus.com/abstracts.a...14&ID=21003835
General Interest Articles
17. Quality of life in adolescent girls with polycystic ovary syndrome.
Arch Pediatr Adolesc Med 2002 Jun;156(6):556-60.
http://www.medifocus.com/abstracts.a...14&ID=22035035
18. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.
J Clin Endocrinol Metab 2002 May;87(5):2128-33.
http://www.medifocus.com/abstracts.a...14&ID=21990209
19. Polycystic ovary syndrome: not ovarian, not simple, unkind.
Hum Fertil (Camb) 2002 Feb;5(1 Suppl):S28-32.
http://www.medifocus.com/abstracts.a...14&ID=21895557
20. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.
J Clin Endocrinol Metab 2002 Mar;87(3):1017-23.
http://www.medifocus.com/abstracts.a...14&ID=21886415
21. Altered vascular function in young women with polycystic ovary syndrome.
J Clin Endocrinol Metab 2002 Feb;87(2):742-6.
http://www.medifocus.com/abstracts.a...14&ID=21826551
22. 'The thief of womanhood': women's experience of polycystic ovarian syndrome.
Social Science & Medicine. 54(3):349-61, 2002 Feb.
http://www.medifocus.com/abstracts.a...14&ID=21682540
23. Polycystic ovarian syndrome and thrombophilia.
Hum Reprod 2002 Feb;17(2):314-9.
http://www.medifocus.com/abstracts.a...14&ID=21679257
24. Blastocyst development and pregnancies after IVF of mature oocytes retrieved from unstimulated patients with PCOS after in-vivo HCG priming.
Hum Reprod 2002 Jan;17(1):134-6.
http://www.medifocus.com/abstracts.a...14&ID=21629180
25. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin.
Hum Reprod 2002 Jan;17(1):76-82.
http://www.medifocus.com/abstracts.a...14&ID=21629169
26. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. [see comments.].
American Journal of Medicine. 111(8):607-13, 2001 Dec 1.
http://www.medifocus.com/abstracts.a...14&ID=21628383
27. Polycystic ovaries in Hirsute women with normal menses.
American Journal of Medicine. 111(8):602-6, 2001 Dec 1.
http://www.medifocus.com/abstracts.a...14&ID=21628382
28. Polycystic ovary syndrome and cancer.
Hum Reprod Update 2001 Nov-Dec;7(6):522-5.
http://www.medifocus.com/abstracts.a...14&ID=21584378
29. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.
Human Reproduction. 16(12):2606-9, 2001 Dec.
http://www.medifocus.com/abstracts.a...14&ID=21583571
30. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.
Human Reproduction. 16(9):1995-8, 2001 Sep.
http://www.medifocus.com/abstracts.a...14&ID=21419217
31. Polycystic ovarian syndrome in women with epilepsy: a review. [Review] [49 refs]
Epilepsia. 42 Suppl 3:60-5, 2001.
http://www.medifocus.com/abstracts.a...14&ID=21411634
32. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome.
Obstetrics & Gynecology. 98(2):325-31, 2001 Aug.
http://www.medifocus.com/abstracts.a...14&ID=21398873
33. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence.
Gynecological Endocrinology. 15(3):170-7, 2001 Jun.
http://www.medifocus.com/abstracts.a...14&ID=21341077
34. On the association between valproate and polycystic ovary syndrome. [see comments]. [Review] [102 refs]
Epilepsia. 42(3):295-304, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21335132
35. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome.
Human Reproduction. 16(6):1086-91, 2001 Jun.
http://www.medifocus.com/abstracts.a...14&ID=21280938
36. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes.
Diabetes Care. 24(6):1050-2, 2001 Jun.
http://www.medifocus.com/abstracts.a...14&ID=21269110
37. Endometrial adenocarcinoma and polycystic ovary syndrome: risk factors, management, and prognosis.
Southern Medical Journal. 94(5):529-31, 2001 May.
http://www.medifocus.com/abstracts.a...14&ID=21265699
38. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome.
Journal of Clinical Endocrinology & Metabolism. 86(3):1175-80, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21135981
39. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
American Journal of Obstetrics & Gynecology. 184(3):289-96, 2001 Feb.
http://www.medifocus.com/abstracts.a...14&ID=21123923
40. Obstetric outcome in women with polycystic ovarian syndrome.
Human Reproduction. 16(2):226-9, 2001 Feb.
http://www.medifocus.com/abstracts.a...14&ID=21102325
41. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome.
Journal of Pediatrics. 138(1):38-44, 2001 Jan.
http://www.medifocus.com/abstracts.a...14&ID=21067150
42. Polycystic ovary disease and the risk of pregnancy-induced hypertension.
Journal of Reproductive Medicine. 45(12):991-4, 2000 Dec.
http://www.medifocus.com/abstracts.a...14&ID=21027202
43. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus.
Journal of Clinical Endocrinology & Metabolism. 85(11):4182-7, 2000 Nov.
http://www.medifocus.com/abstracts.a...14&ID=20544560
44. The prevalence of polycystic ovaries in women with a history of gestational diabetes.
Clinical Endocrinology. 53(4):501-7, 2000 Oct.
http://www.medifocus.com/abstracts.a...14&ID=20467077
45. Polycystic ovaries and recurrent miscarriage--a reappraisal.
Human Reproduction. 15(3):612-5, 2000 Mar.
http://www.medifocus.com/abstracts.a...14&ID=20153542
Drug Therapy
46. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome.
Fertil Steril 2002 Jun;77(6):1128-35.
http://www.medifocus.com/abstracts.a...14&ID=22053082
47. Prediction of the effect of metformin treatment in patients with polycystic ovary syndrome.
Gynecol Obstet Invest 2002;53(2):100-4.
http://www.medifocus.com/abstracts.a...14&ID=21958863
48. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome.
Fertil Steril 2002 Mar;77(3):520-5.
http://www.medifocus.com/abstracts.a...14&ID=21861743
49. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome.
Journal of Clinical Endocrinology & Metabolism. 87(2):524-9, 2002 Feb.
http://www.medifocus.com/abstracts.a...14&ID=21826517
50. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome.
Fertil Steril 2002 Feb;77(2):209-15.
http://www.medifocus.com/abstracts.a...14&ID=21679138
51. Use of metformin in polycystic ovary syndrome.
Ann Pharmacother 2001 Dec;35(12):1644-7.
http://www.medifocus.com/abstracts.a...14&ID=21651723
52. Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome.
Human Reproduction. 16(11):2263-6, 2001 Nov.
http://www.medifocus.com/abstracts.a...14&ID=21536808
53. Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome.
Archives of Gynecology & Obstetrics. 265(3):124-7, 2001 Aug.
http://www.medifocus.com/abstracts.a...14&ID=21445642
54. Use of insulin-sensitizing agents in patients with polycystic ovary syndrome. [Review] [74 refs]
Endocrine Practice. 7(4):279-86, 2001 Jul-Aug.
http://www.medifocus.com/abstracts.a...14&ID=21389305
55. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Journal of Clinical Endocrinology & Metabolism. 86(6):2428-36, 2001 Jun.
http://www.medifocus.com/abstracts.a...14&ID=21290999
56. Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?.
Human Reproduction. 16(5):940-4, 2001 May.
http://www.medifocus.com/abstracts.a...14&ID=21231225
57. Insulin-lowering drugs in polycystic ovary syndrome. [Review] [55 refs]
Obstetrics & Gynecology Clinics of North America. 28(1):153-64, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21188638
58. Limited ovarian stimulation (LOS), prevents the recurrence of severe forms of ovarian hyperstimulation syndrome in polycystic ovarian disease.
European Journal of Obstetrics, Gynecology, & Reproductive Biology. 94(2):245-9, 2001 Feb.
http://www.medifocus.com/abstracts.a...14&ID=21098637
59. Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome.
Human Reproduction. 16(1):36-42, 2001 Jan.
http://www.medifocus.com/abstracts.a...14&ID=21066205
60. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. [Review] [58 refs]
Cochrane Database of Systematic Reviews [computer file]. (4):CD000410, 2000.
http://www.medifocus.com/abstracts.a...14&ID=21061792
61. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome. [Review] [4 refs]
Cochrane Database of Systematic Reviews [computer file]. (2):CD000412, 2000.
http://www.medifocus.com/abstracts.a...14&ID=20257798
62. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome. [Review] [6 refs]
Cochrane Database of Systematic Reviews [computer file]. (2):CD000087, 2000.
http://www.medifocus.com/abstracts.a...14&ID=20257770
63. Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome. [Review] [3 refs]
Cochrane Database of Systematic Reviews [computer file]. (2):CD000097, 2000.
http://www.medifocus.com/abstracts.a...14&ID=20257578
Surgical Therapy
64. Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome.
Journal of the American Association of Gynecologic Laparoscopists. 8(4):511-8, 2001 Nov.
http://www.medifocus.com/abstracts.a...14&ID=21534615
65. Transvaginal ovarian drilling: a new surgical treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome.
Fertility & Sterility. 76(4):812-6, 2001 Oct.
http://www.medifocus.com/abstracts.a...14&ID=21475634
66. Ovarian size and response to laparoscopic ovarian electro-cauterization in polycystic ovarian disease.
International Journal of Gynaecology & Obstetrics. 74(3):269-74, 2001 Sep.
http://www.medifocus.com/abstracts.a...14&ID=21429170
67. Polycystic ovarian syndrome: a follow-up study on fertility and menstrual pattern in 149 patients 15-25 years after ovarian wedge resection.
Human Reproduction. 16(7):1479-85, 2001 Jul.
http://www.medifocus.com/abstracts.a...14&ID=21319043
68. Does laparoscopic ovarian diathermy affect the outcome of IVF-embryo transfer in women with polycystic ovarian syndrome? A retrospective comparative study.
Human Reproduction. 16(1):91-95, 2001 Jan.
http://www.medifocus.com/abstracts.a...14&ID=21066195
69. Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. [Review] [9 refs]
Cochrane Database of Systematic Reviews [computer file]. (2):CD001122, 2000.
http://www.medifocus.com/abstracts.a...14&ID=20257826
Clinical Trials
70. The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome.
Fertil Steril 2002 Jun;77(6):1136-40.
http://www.medifocus.com/abstracts.a...14&ID=22053083
71. Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome.
Fertil Steril 2002 Jun;77(6):1125-7.
http://www.medifocus.com/abstracts.a...14&ID=22053081
72. Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial.
Hum Reprod 2002 Feb;17(2):289-94.
http://www.medifocus.com/abstracts.a...14&ID=21679252
73. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome.
Fertility & Sterility. 77(1):101-6, 2002 Jan.
http://www.medifocus.com/abstracts.a...14&ID=21638205
74. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment.
Hormone Research. 55(5):224-8, 2001.
http://www.medifocus.com/abstracts.a...14&ID=21601336
75. Insulin resistance in clomiphene responders and non-responders with polycystic ovarian disease and therapeutic effects of metformin.
International Journal of Gynaecology & Obstetrics. 75(1):43-50, 2001 Oct.
http://www.medifocus.com/abstracts.a...14&ID=21482012
76. Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance.
Human Reproduction. 16(10):2066-72, 2001 Oct.
http://www.medifocus.com/abstracts.a...14&ID=21458615
77. Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).
Journal of Adolescent Health. 29(3):160-9, 2001 Sep.
http://www.medifocus.com/abstracts.a...14&ID=21415629
78. Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study.
Journal of Endocrinological Investigation. 24(7):483-90, 2001 Jul-Aug.
http://www.medifocus.com/abstracts.a...14&ID=21399518
79. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.
Journal of Clinical Endocrinology & Metabolism. 86(4):1626-32, 2001 Apr.
http://www.medifocus.com/abstracts.a...14&ID=21195505
80. Operative transvaginal hydrolaparoscopy for treatment of polycystic ovary syndrome: a new minimally invasive surgery.
Fertility & Sterility. 75(3):607-11, 2001 Mar.
http://www.medifocus.com/abstracts.a...14&ID=21135620
81. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study.
Fertility & Sterility. 75(1):46-52, 2001 Jan.
http://www.medifocus.com/abstracts.a...14&ID=21099924
82. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
Gynecological Endocrinology. 14(6):411-6, 2000 Dec.
http://www.medifocus.com/abstracts.a...14&ID=21118997
83. Long-term GnRH analogue treatment is equivalent to laparoscopic laser diathermy in polycystic ovarian syndrome patients with severe ovarian dysfunction.
Human Reproduction. 15(12):2526-30, 2000 Dec.
http://www.medifocus.com/abstracts.a...14&ID=20551294
84. Coasting may reduce the severity of the ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome.
Gynecologic & Obstetric Investigation. 50(3):186-8, 2000.
http://www.medifocus.com/abstracts.a...14&ID=20469385
85. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome.
Human Reproduction. 15(1):165-70, 2000 Jan.
http://www.medifocus.com/abstracts.a...14&ID=20079211
Complementary Medicine
86. Polycystic ovary syndrome: clinical considerations. [Review] [126 refs]
Alternative Medicine Review. 6(3):272-92, 2001 Jun.
http://www.medifocus.com/abstracts.a...14&ID=21303009
87. Effects of electro-acupuncture on anovulation in women with polycystic ovary syndrome.
Acta Obstetricia et Gynecologica Scandinavica. 79(3):180-8, 2000 Mar.
http://www.medifocus.com/abstracts.a...14&ID=20179042
88. Induction of ovulation by Sairei-to for polycystic ovary syndrome patients.
Endocrine Journal. 46(1):217-20, 1999 Feb.
http://www.medifocus.com/abstracts.a...14&ID=99353662
TONS of links to PCOS research...TONS, TONS, TONS!!! 
